Prof Ana Santos Rutschman talks about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.

Dr Steven Goodman talks about the ethical and scientific implications of breaking the blind of placebo-controlled COVID-19 vaccine trials.

Dr Arthur Caplan talks about ethical issues surrounding the development, production, and use of potential SARS-CoV-2 vaccine.

Dr Caleb Alexander examines the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Drs Stefano Bertozzi and Jeffrey Mackie-Mason talk about business models of scientific publishing that advance biomedical knowledge and discovery.

Disparities in children’s mental health care could be addressed through expansion of school-based programs via passage of the Mental Health in Schools Act.

Due to insurance company regulations, current restrictions on access to mental health care prevent many from obtaining needed care.

There are many misconceptions about psychiatry as a science that contribute to the continued social stigmatization of mental illnesses.

Training in the humanities helps to provide psychiatrists with an insight into the human condition, as represented in literature, film, and other media forms.

Summary of federal and state autism-specific legislation that governs insurance coverage for those with autism spectrum disorder and their caregivers.